Translational Research in the Molecular Imaging Research Centre

Professor Steve Archibald S.J.Archibald@hull.ac.uk
Professor in Molecular Imaging

New technology to improve capability for clinical radiopharmaceutical production Jan 1, 2019 - Feb 28, 2022
Medical imaging techniques rely on radioactive atoms that don't last for a long time and so methods need to be developed to handle them on hospital sites or close by. Essentially this is drug factory near to the patient as the material is decaying al... Read More about New technology to improve capability for clinical radiopharmaceutical production.

Positron Emission Tomography research Mar 1, 2016 - Feb 28, 2017

Training scientists to develop and Image materials for Tissue Engineering and Regenerative Medicine (iTERM) Oct 1, 2013 - Sep 30, 2017
With an increasingly aging population, new treatment solutions for diseased, defective, or damaged tissues need to be developed. Although human donor material would be preferable for these purposes, this is often not available and often associated wi... Read More about Training scientists to develop and Image materials for Tissue Engineering and Regenerative Medicine (iTERM).

Medical Imaging Alliance: Siberia and Hull Sep 3, 2018 - Sep 2, 2019
British Council Newton Trust monies for a workshop in Novosibirsk on the topic of medical imaging. Aim is to forge good links with universities there and then apply for larger funds.

Novel dual CXCR4/CXCR7 receptor drugs: targeting secondary disease progression and resistance to immunotherapy in breast cancer Aug 1, 2019 - Jul 31, 2023
CXCR4/CXCR7-CXCL12 chemokine axis plays a pivotal role in breast cancer (BC) growth, survival, therapy evasion and metastasis. Clinically overexpression of CXCR4/CXCR7-CXCL12 correlates with aggressive BC disease and poor outcome. Evidence suggests c... Read More about Novel dual CXCR4/CXCR7 receptor drugs: targeting secondary disease progression and resistance to immunotherapy in breast cancer.